Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Clinicobacteriological and Histopathological Correlation in Leprosy in a Tertiary Care Centre: A Study of 220 cases

Chavda A, Rathwa M, Shah H, et al. Indian Journal of Leprosy. 2023;
Download PDF
Publication

Global Health DermatologyOral presentationsGD01 Comparative efficacy of Mycobacterium indicus pranii and bacille Calmette–Guérin as immunotherapeutic adjuncts in multibacillary leprosy: a clinical and molecular randomized controlled trial

Jain S, Chhabra S, Dogra S, et al. Oxford University Press (OUP). British Journal of Dermatology. 2024;
Publication

Changes in the Cutaneous Nerve Fiber Staining and Distribution of PGP9.5 in Clinically Uninvolved Skin in Leprosy Patients after Completion of Multidrug Therapy and Assessing PGP9.5 as a Marker of Treatment Response

Thakur V, Narang T, Bishnoi A, et al. Medknow. Indian Dermatology Online Journal. 2024; 15 (4) : 599-604.
Download PDF
Publication

Borderline leprosy with unilateral blepharoptosis in reversal reaction

Palaniappan V, Raveendran P, Karthikeyan K. Medknow. Oman Journal of Ophthalmology. 2024; 17 (2) : 299-300.
Download PDF
Publication

A case report on imaging findings of rare segmental necrotizing granulomatous neuritis of leprosy involving ulnar nerve.

Netam S, Gupta N, Chandrakar N. Qatar medical journal. 2024; 2024 (3) : 1-7.
Download PDF
Publication

Central Serous Chorioretinopathy in a Patient with Hansen’s Disease with Type 1 Lepra Reaction - A Case Report

Singh T, Narang T, Yakang D. Indian Journal of Leprosy. 2024;
Download PDF
Publication

Morbimortalidade por Reações em Hanseníase

Ribeiro Filha Coriolano C. Universidade de Brasília. Faculdade de Ciências da Saúde. 2021;
Download PDF
Publication

Late relapses in leprosy patients in Brazil: 10-year post-trial of uniform multidrug therapy (U-MDT/CT-BR)

Penna GO, Pontes MADA, Talhari S, et al. Elsevier BV. The Brazilian Journal of Infectious Diseases. 2024; 28 (2) : 1-8.
Download PDF
Publication

Associação do poliformismo rs2228570 no gene VDR com o desfecho terapêutico em hanseníase

Gasparini Bernardes B. Instituto Lauro de Souza Lima . Secretaria de Estado da Saúde de São Paulo. 2024;
Download PDF
Publication

A Cross-Sectional Study of the Success of the Leprosy Elimination Strategy before and after a 10-Year Eradication Period in a Referral Hospital in Tamil Nadu, India

Sundaramoorthy A, Hemachandran K, Abilash VG, et al. B P International. Medical Research and Its Applications Vol. 6. 2024;

Pagination

  • Previous page ‹‹
  • Page 8
  • Next page ››
Subscribe to Multi-drug therapy (MDT)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2025 InfoNTD